Contact
Please use this form to send email to PR contact of this press release:
Press Release: Tolebrutinib regulatory submission accepted for priority review in the US for patients with multiple sclerosis
TO:
Please use this form to send email to PR contact of this press release:
Press Release: Tolebrutinib regulatory submission accepted for priority review in the US for patients with multiple sclerosis
TO: